ZNF788 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.44089209850063E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.55351295663786E-15 |
Normal-vs-Stage2 |
2.664800E-03 |
Normal-vs-Stage3 |
2.844700E-04 |
Normal-vs-Stage4 |
6.79839962103301E-10 |
Stage1-vs-Stage2 |
7.251200E-01 |
Stage1-vs-Stage3 |
5.980200E-01 |
Stage1-vs-Stage4 |
2.549400E-01 |
Stage2-vs-Stage3 |
9.501200E-01 |
Stage2-vs-Stage4 |
2.306000E-01 |
Stage3-vs-Stage4 |
1.421780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62714286489063E-12 |
Normal-vs-AfricanAmerican |
2.70599997964638E-09 |
Normal-vs-Asian |
4.379800E-02 |
Caucasian-vs-AfricanAmerican |
4.784400E-01 |
Caucasian-vs-Asian |
8.229800E-01 |
AfricanAmerican-vs-Asian |
9.781400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.44089209850063E-16 |
Normal-vs-Female |
2.16480000037045E-07 |
Male-vs-Female |
5.029700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.01139999708622E-08 |
Normal-vs-Extreme_Weight |
1.62547753035369E-12 |
Normal-vs-Obese |
2.72699995917947E-09 |
Normal-vs-Extreme_Obese |
4.3504999602817E-09 |
Normal_Weight-vs-Extreme_Weight |
6.379400E-01 |
Normal_Weight-vs-Obese |
5.003400E-01 |
Normal_Weight-vs-Extreme_Obese |
3.300400E-01 |
Extreme_Weight-vs-Obese |
1.585760E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.350800E-01 |
Obese-vs-Extreme_Obese |
1.552040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.00340000144905E-09 |
Normal-vs-Age(41-60Yrs) |
2.11575201802816E-12 |
Normal-vs-Age(61-80Yrs) |
1.62680979798324E-12 |
Normal-vs-Age(81-100Yrs) |
1.048180E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.479600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.301200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.195000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.815000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.64335212105016E-12 |
Normal-VS-Type2 PRCC |
2.97772917434713E-12 |
Normal-VS-KIRP CIMP |
5.80102632596891E-12 |
Normal-VS-Unclassified PRCC |
2.819200E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.759800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.241080E-03 |
Type1 PRCC-VS-Unclassified PRCC |
4.930400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.558160E-02 |
Type2 PRCC-VS-Unclassified PRCC |
1.852440E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.560400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.74338321556888E-12 |
Normal-vs-N1 |
2.759800E-04 |
Normal-vs-N2 |
3.90369999658802E-08 |
N0-vs-N1 |
8.866600E-01 |
N0-vs-N2 |
1.156000E-01 |
N1-vs-N2 |
9.023800E-02 |
|
|